Why does NAFLD predict type 2 diabetes? (Q37856880)

24 August 2017

1 reference

title

Why does NAFLD predict type 2 diabetes? (English)

1 reference

24 August 2017

0 references

Gianluca Perseghin

3

0 references

author name string

Guido Lattuada

series ordinal

1

1 reference

PubMed ID

21431854

24 August 2017

Francesca Ragogna

series ordinal

2

1 reference

24 August 2017

1 June 2011

1 reference

24 August 2017

Current diabetes report

1 reference

24 August 2017

11

1 reference

24 August 2017

3

1 reference

24 August 2017

167-172

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-011-0190-2

24 August 2017

0 references

cites work

From mice to men: insights into the insulin resistance syndromes

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Glucose tolerance and diabetes in chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Regulation of glucose homeostasis in humans with denervated livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Identification and characterization of metabolically benign obesity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Primacy of Hepatic Insulin Resistance in the Development of the Metabolic Syndrome Induced by an Isocaloric Moderate-Fat Diet in the Dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Hepatic overexpression of glycerol-sn-3-phosphate acyltransferase 1 in rats causes insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

The HISS story overview: a novel hepatic neurohumoral regulation of peripheral insulin sensitivity in health and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Association of nonalcoholic fatty liver disease with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Elevated fasting plasma C-peptide occurs in non-diabetic individuals with fatty liver, irrespective of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Liver fat in the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Lack of association of liver fat with model parameters of beta-cell function in men with impaired glucose tolerance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Pancreatic fat content and beta-cell function in men with and without type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Ectopic fat storage in the pancreas, liver, and abdominal fat depots: impact on β-cell function in individuals with impaired glucose metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Effect of liver fat on insulin clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study. The D.E.S.I.R. Study (Data from an Epidemiological Study on the Insulin Resistance syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Alanine aminotransferase, gamma-glutamyltransferase (GGT) and all-cause mortality: results from a population-based Danish twins study alanine aminotransferase, GGT and mortality in elderly twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Large-scale population analysis reveals an extremely low threshold for "non-healthy" alanine aminotransferase that predicts diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Effects of nonalcoholic fatty liver disease on the development of metabolic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0190-2

Cirrhosis and diabetes. I. Increased incidence of diabetes in patients with Laennec's cirrhosis

21 January 2018

1 reference

12 December 2020

Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation

1 reference

12 December 2020

Glucose metabolism in cirrhosis: a review with some perspectives for the future

1 reference

12 December 2020

Cellular mechanism of insulin resistance: potential links with inflammation

1 reference

12 December 2020

Defective insulin action on protein and glucose metabolism during chronic hyperinsulinemia in subjects with benign insulinoma

1 reference

12 December 2020

Cirrhosis and diabetes. II. Association of impaired glucose tolerance with portal-systemic shunting in Laennec's cirrhosis

1 reference

12 December 2020

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

12 December 2020

Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients

1 reference

12 December 2020

Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.

1 reference

12 December 2020

Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins

1 reference

12 December 2020

Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men

1 reference

12 December 2020

A liver factor increasing glucose uptake in rat hindquarters

1 reference

12 December 2020

Incidence of altered glucose tolerance in liver cirrhosis

1 reference

12 December 2020

10.1007/S11892-011-0190-2

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21431854